BrightSpring Health Services, Inc. (BTSG) Guidance & Earnings Results

On 2026-07-31 BrightSpring Health Services, Inc. raised guidance: "FY2026 Revenue $15,100M-$15,425M (17.0%-19.5% growth); Pharmacy Segment Revenue $13,200M-$13,500M (15.3%-17.9% growth); Provider Segment Revenue $1,900M-$1,925M (29.7%-31.4% growth); Total Adjusted EBITDA $820M-$845M…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BTSGBrightSpring Health Services, Inc.Follow BTSG — free

Health Information Services · Healthcare

—

Price chart with a free account

Market cap: 11.9B
P/E TTM: 36.2
Dividend yield: —
52-week: —
Next earnings: 30 Oct, in 6 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
31 Jul 26	Raised	FY2026 Revenue $15,100M-$15,425M (17.0%-19.5% growth); Pharmacy Segment Revenue $13,200M-$13,500M (15.3%-17.9% growth); Provider Segment Revenue $1,900M-$1,925M (29.7%-31.4% growth); Total Adjusted EBITDA $820M-$845M (32.8%-36.8% growth) · full year
1 May 26	Raised	Increased full year 2026 Revenue and Adjusted EBITDA guidance · full year
27 Feb 26	Raised	FY2026 Revenue and Adjusted EBITDA guidance initiated; growth rates vs FY2025 excluding Community Living · full year
28 Oct 25	Raised	Revenue guidance raised to $12.5B-$12.8B (24-27% growth); Adjusted EBITDA guidance reiterated at $605-$615M (31.5-33.7% growth) · full year
20 Oct 25	Raised	Revenue guidance raised to $12.4B-$12.7B (23.1%-26.1% growth); Adj. EBITDA guidance raised to $605M-$615M (31.5%-33.7% growth) · full year
1 Aug 25	Raised	FY2025 Revenue $12,200-12,600M (21.1-25.1% growth); Pharmacy Segment Revenue $10,750-11,100M (22.8-26.8% growth); Provider Segment Revenue $1,450-1,500M (10.0-13.8% growth); Adjusted EBITDA $590-605M (28.2-31.5% growth) · full year

BrightSpring Health Services, Inc. — questions

What guidance did BrightSpring Health Services, Inc. give?: On 2026-07-31: "FY2026 Revenue $15,100M-$15,425M (17.0%-19.5% growth); Pharmacy Segment Revenue $13,200M-$13,500M (15.3%-17.9% growth); Provider Segment Revenue $1,900M-$1,925M (29.7%-31.4% growth); Total Adjusted EBITDA $820M-$845M (32.8%-36.8% growth)"
When does BrightSpring Health Services, Inc. report earnings?: BrightSpring Health Services, Inc.'s next earnings report is expected on 2026-10-30.

Every figure on this page comes from BrightSpring Health Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.